相关产品推荐更多 >

Interferon alpha-B 蛋白|Interferon alpha-B protein|Interferon alpha-B(Cynomolgus, Fc Tag)
¥2980
FLT4 蛋白|FLT4 protein|FLT4(Mouse, Fc Tag)
¥3870
ART4 / CD297 蛋白|ART4 / CD297 protein|ART4 / CD297(Rat, His Tag)
¥4520
TWEAK / TNFSF12 蛋白|TWEAK / TNFSF12 protein|TWEAK / TNFSF12(Rat, Fc Tag)
¥2980
Osteomodulin 蛋白|Osteomodulin protein|Osteomodulin(Mouse, His Tag)
¥3870
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 规格:
100 µg/1 mg
| 规格: | 100 µg | 产品价格: | ¥3870 |
|---|---|---|---|
| 规格: | 1 mg | 产品价格: | ¥22770 |
蛋白名称:EGFR蛋白, EGFR protein
蛋白构建:A DNA sequence encoding the extracellular domain of mouse EGFR (Q01279) (Met 1-Ser 647) was fused with a polyhistidine tag at the C-terminus.
表达宿主:HEK293 Cells
蛋白纯度:> 95 % as determined by SDS-PAGE
蛋白活性:1. Measured by its binding ability in a functional ELISA. 2. Immobilized mouse EGFR-his at 10 μg/mL (100 μl/well) can bind human EGF-Fc (Cat:10605-H01H), The EC50 of human EGF-Fc (Cat:10605-H01H) is 60-90 ng/mL. 3. Immobilized mouse EGFR-his at 10 μg/mL (100 μl/well) can bind mouse EGF-Fc (Cat:50482-M01H), The EC50 of mouse EGF-Fc (Cat:50482-M01H) is 70-100 ng/mL.
蛋白内毒素:< 1.0 EU per μg of the protein as determined by the LAL method
预测N端:Leu 25
蛋白分子量:The secreted recombinant mouse EGFR comprises 634 amino acids and has a calculated molecular mass of 71 kDa. As a result of glycosylation, the apparent molecular mass of rmEGFR is approximately 100 kDa in SDS-PAGE under reducing conditions.
蛋白NP号:Q01279
蛋白氨基酸序列:Met1-Ser647
蛋白标签:C-His
蛋白保存条件:Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验受体阳性的乳腺癌细胞有较小程度的细胞毒性,这种情况与在异种移植小鼠模型中的表现一致。体外实验中,在 TNBC 细胞的诱导下,初始 EGFR CAR-T 迅速扩增,同时还会激活 interferomγ, granzyme-perforin-PARP 和 FaS-FADD-caspase 等相关信号通路。 实验团队首先通过免疫印迹和流式细胞术的方法验证 EGFR 高表达于三阴乳腺癌。其中免疫印迹(immunoblotting)又称蛋白质印迹(Western blotting),是根据抗原抗体的特异性结合检测
Clinical Advancement of EGFR Inhibitors in Cancer Therapy
The epidermal growth factor receptor (EGFR) represents one of the most promising molecular targets in cancer therapeutics. An array of EGFR inhibitory drugs have been developed that are progressing rapidly in oncology clinical trials
Phosphotyrosine Kinase Assays as a Prescreen for Inhibitors of EGFr
The epidermal growth factor receptor (EGFr) is a 170-kDa glycosylated transmembrane protein found in a wide variety of tissues (1 ). It is the receptor for epidermal growth factor (EGF), transforming growth factor α (TGFα), and other related
技术资料暂无技术资料 索取技术资料





